Cargando…
Immunosuppressive adenosine-targeted biomaterials for emerging cancer immunotherapy
Immunotherapy has paved the way for the future of cancer therapy, but there are still significant challenges to be overcome, such as the occurrence of immune escape or suppression. Adenosine is essential in modulating the immune responses of immune cells and maintaining immune tolerance. Emerging ad...
Autores principales: | Wei, Qi, Zhang, Lening, Zhao, Nan, Cheng, Zhihua, Xin, Hua, Ding, Jianxun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9641176/ https://www.ncbi.nlm.nih.gov/pubmed/36389700 http://dx.doi.org/10.3389/fimmu.2022.1012927 |
Ejemplares similares
-
Targeting Adenosine in Cancer Immunotherapy to Enhance T-Cell Function
por: Vigano, Selena, et al.
Publicado: (2019) -
Adenosine signaling: Optimal target for gastric cancer immunotherapy
por: Wang, Junqing, et al.
Publicado: (2022) -
Editorial: Adenosine pathways in cancer immunity and immunotherapy
por: Fu, Junjiang, et al.
Publicado: (2023) -
The immunosuppressive microenvironment and immunotherapy in human glioblastoma
por: Zhang, Xuehua, et al.
Publicado: (2022) -
Intestinal Bacteria Encapsulated by Biomaterials Enhance Immunotherapy
por: Liu, Yilun, et al.
Publicado: (2021)